On Holding Sinks 20.29% After Sales Miss and Lowered 2026 Growth Outlook
On Holding Stock Plunges 20.29% on Worst Day Ever After Sales Miss, Lowered OutlookOn Holding AG Stock Tumbles After Disappointing Q2 Sales, Resisting US MarkdownsOn Reports SFr105m Net Income, SFr850.3m Sales in Q2 2026FiscalNote Q2 2026 slides: AI pivot amid revenue pressure, stock near lows By Investing.comOn Holding Shares Drop 16% on Mixed Q2 Results, Reduced GuidanceOn Holding Shares Drop 22% on Q2 Revenue Miss, Reduced Sales OutlookCeva Beats Estimates, But Shares Plunge on Weak GuidanceJefferies downgraded Apple to underperform from hold and lowered its price target on shares to $263.66 from $285.56, suggesting nearly 16% downside from Friday’s close. CNBC's MacKenzie Sigalos has ...#ResultsReview , Zydus Lifescience: , -Mix results, -Revenue slightly higher and EBITDA as per expectations, -Margins 1% lower than estimates at 23.35%, -Stock fell 3% after results then recovered , ...Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut — TradingView News